Bortezomib plus melphalan and prednisone (VMP regimen) as the initial treatment for IgE multiple myeloma: a case study

被引：8
|
作者：
Sato, Hiroyuki [1 ]
Komiya, Yusuke [1 ]
Hoshino, Shigeru [1 ]
机构：
[1] Saitama Red Cross Hosp, Dept Hematol, Chuo Ku, Saitama 3388553, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2014年 / 99卷 / 06期
关键词：
Multiple myeloma; IgE; Bortezomib; VMP regimen; Initial treatment; PLASMA-CELL LEUKEMIA; MAINTENANCE; THALIDOMIDE; EFFICACY; TRIAL; LEVEL; RARE;
D O I：
10.1007/s12185-014-1571-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with IgE multiple myeloma have poor prognosis. Due to the rarity of this condition, no standard treatment has been developed. As the VMP regimen (bortezomib plus melphalan and prednisone) has been reported to be highly effective in the treatment of other types of myeloma, we treated a patient with newly diagnosed IgE myeloma using the VMP regimen. Her myeloma responded well to VMP regimen. The results of this case report thus suggest that physicians may consider VMP regimen for use as the initial treatment for IgE myeloma.
引用
收藏
页码：786 / 789
页数：4
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (RD) VERSUS BORTEZOMIB PLUS MELPHALAN AND PREDNISONE (VMP)
    Cavenagh, J. D.
    Belch, A. R.
    Hulin, C.
    Basu, S.
    White, D.
    Ervin-Haynes, A.
    Marek, J.
    Pelligra, C. G.
    Guo, S.
    Binder, G.
    Monzini, M. S.
    Facon, T.
    HAEMATOLOGICA, 2014, 99 : 379 - 379
  • [32] Combination chemotherapy vs melphalan plus prednisone as treatment for multiple myeloma
    Tanner, J
    Dunst, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (10) : 532 - 532
  • [33] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
    Mateos, Maria-Victoria
    Cavo, Michele
    Blade, Joan
    Dimopoulos, Meletios A.
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Cook, Mark
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Krevvata, Maria
    Wang, Jianping
    Kudva, Anupa
    Ukropec, Jon
    Wroblewski, Susan
    Kobos, Rachel
    San-Miguel, Jesus
    BLOOD, 2019, 134
  • [34] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
    Mateos, Maria-Victoria
    Dimopoulos, Meletios A.
    Cavo, Michele
    Suzuki, Kenshi
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Grosicki, Sebastian
    Crepaldi, Andre
    Liberati, Anna Marina
    Campbell, Philip
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Iida, Shinsuke
    Blade, Joan
    Ukropec, Jon
    Pei, Huiling
    Van Rampelbergh, Rian
    Kudva, Anupa
    Qi, Ming
    San-Miguel, Jesus
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : 785 - 798
  • [35] Bortezomib- melphalan-prednisone: what pattern for bortezomib in multiple myeloma?
    Fouquet, Guillemette
    Leleu, Xavier
    HEMATOLOGIE, 2015, 21 (03): : 157 - 159
  • [36] Comparative Efficacy and Safety of Daratumumab in Combination with Bortezomib, Melphalan, and Prednisone (D-VMP) in Alcyone Versus Bortezomib, Melphalan, and Prednisone (VMP) in Vista in Newly Diagnosed Multiple Myeloma (NDMM) Patients Using Propensity Score Matching (PSM)
    Cavo, Michele
    Dimopoulos, Meletios A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Jakubowiak, Andrzej
    Deraedt, William
    Lam, Annette
    Kampfenkel, Tobias
    Qi, Ming
    He, Jianming
    BLOOD, 2018, 132
  • [37] BORTEZOMIB PLUS MELPHALAN AND PREDNISONE IN UNTREATED PATIENS WITH MULTIPLE MYELOMA INELIGIBLE FOR STEM CELL TRASPLANTATION
    Sanchez, R. Garcia
    Entrena, L.
    Hernandez, A.
    Gonzalez, P.
    Puerta, J. M.
    Pascual, A.
    Castellanos, M.
    Morales, E.
    Casanova, M.
    Bailen, A.
    Duran, S.
    Almagro, M.
    Ramirez, G.
    Del Castillo, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 592 - 592
  • [38] MELPHALAN AND PREDNISONE PLUS TOTAL BONE-MARROW IRRADIATION AS INITIAL TREATMENT FOR MULTIPLE-MYELOMA
    MCINTYRE, OR
    TEFFT, M
    PROPERT, K
    WOLF, DJ
    COLEMAN, M
    LEONE, L
    COOPER, MR
    EATON, W
    ZIMMER, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (04): : 1007 - 1012
  • [39] BORTEZOMIB (VELCADE)-MELPHALAN-PREDNISONE (VMP) VERSUS VELCADE-THALIDOMIDE-PREDNISONE (VTP) IN ELDERLY UNTREATED MULTIPLE MYELOMA (MM) PATIENTS
    Mateos, M. V.
    Oriol, A.
    Martinez, J.
    Cibeira, M. T.
    de Paz, R.
    Terol, M. J.
    Garcia-Larana, J.
    Bengoechea, E.
    Martinez, R.
    Martin, A.
    de Arriba, F.
    Palomera, L.
    Hernandez, J. M.
    Bello, J. L.
    Martin, M. L.
    Gonzalez, Y.
    Lahuerta, J. J.
    Blade, J.
    San Miguel, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 190 - 190
  • [40] Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Dmide
    Cavalli, Maide
    Ria, Roberto
    Gentilini, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Vincelli, Donatella
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Pautasso, Chiara
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Cangialosi, Clotilde
    Mansueto, Giovanna
    Liberati, Anna Marina
    Magarotto, Valeria
    Omede, Paola
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Boccadoro, Mario
    BLOOD, 2012, 120 (21)
12345